Vasomotor Symptoms of Menopause Treatment Market Report

Japan Vasomotor Symptoms of Menopause Treatment Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 17, 2019
  • PAGES：140
  • REPORT CODE：GMM285057
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Vasomotor Symptoms of Menopause Treatment market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Vasomotor Symptoms of Menopause Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Vasomotor Symptoms of Menopause Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • EndoCeutics, Inc.

    • Mithra Pharmaceuticals S.A.

    • Amgen Inc.

    • Euroscreen S.A.

    • Pherin Pharmaceuticals, Inc.

    • Euroscreen SA.

    • Mithra Pharmaceuticals SA

    • Pivot Pharmaceuticals Inc.

    • MenoGeniX, Inc.


    By Type:

    • Estetrol

    • Fezolinetant

    • FP-101

    • HBN-2

    • Others


    By End-User:

    • Hospital

    • Homecare

    • Clinic


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Vasomotor Symptoms of Menopause Treatment Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Estetrol from 2014 to 2026

      • 1.3.2 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Fezolinetant from 2014 to 2026

      • 1.3.3 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of FP-101 from 2014 to 2026

      • 1.3.4 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of HBN-2 from 2014 to 2026

      • 1.3.5 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Homecare from 2014 to 2026

      • 1.4.3 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Vasomotor Symptoms of Menopause Treatment Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Vasomotor Symptoms of Menopause Treatment by Major Types

      • 3.4.1 Market Size and Growth Rate of Estetrol

      • 3.4.2 Market Size and Growth Rate of Fezolinetant

      • 3.4.3 Market Size and Growth Rate of FP-101

      • 3.4.4 Market Size and Growth Rate of HBN-2

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Vasomotor Symptoms of Menopause Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Vasomotor Symptoms of Menopause Treatment by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Vasomotor Symptoms of Menopause Treatment in Hospital

      • 4.4.2 Market Size and Growth Rate of Vasomotor Symptoms of Menopause Treatment in Homecare

      • 4.4.3 Market Size and Growth Rate of Vasomotor Symptoms of Menopause Treatment in Clinic


    5 Market Analysis by Regions

    • 5.1 Japan Vasomotor Symptoms of Menopause Treatment Production Analysis by Regions

    • 5.2 Japan Vasomotor Symptoms of Menopause Treatment Consumption Analysis by Regions


    6 Hokkaido Vasomotor Symptoms of Menopause Treatment Landscape Analysis

    • 6.1 Hokkaido Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

    • 6.2 Hokkaido Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users


    7 Tohoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis

    • 7.1 Tohoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

    • 7.2 Tohoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users


    8 Kanto Vasomotor Symptoms of Menopause Treatment Landscape Analysis

    • 8.1 Kanto Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

    • 8.2 Kanto Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users


    9 Chubu Vasomotor Symptoms of Menopause Treatment Landscape Analysis

    • 9.1 Chubu Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

    • 9.2 Chubu Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users


    10 Kinki Vasomotor Symptoms of Menopause Treatment Landscape Analysis

    • 10.1 Kinki Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

    • 10.2 Kinki Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users


    11 Chugoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis

    • 11.1 Chugoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

    • 11.2 Chugoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users


    12 Shikoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis

    • 12.1 Shikoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

    • 12.2 Shikoku Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users


    13 Kyushu Vasomotor Symptoms of Menopause Treatment Landscape Analysis

    • 13.1 Kyushu Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

    • 13.2 Kyushu Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 EndoCeutics, Inc.

      • 14.1.1 EndoCeutics, Inc. Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Mithra Pharmaceuticals S.A.

      • 14.2.1 Mithra Pharmaceuticals S.A. Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Amgen Inc.

      • 14.3.1 Amgen Inc. Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Euroscreen S.A.

      • 14.4.1 Euroscreen S.A. Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Pherin Pharmaceuticals, Inc.

      • 14.5.1 Pherin Pharmaceuticals, Inc. Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Euroscreen SA.

      • 14.6.1 Euroscreen SA. Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Mithra Pharmaceuticals SA

      • 14.7.1 Mithra Pharmaceuticals SA Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Pivot Pharmaceuticals Inc.

      • 14.8.1 Pivot Pharmaceuticals Inc. Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 MenoGeniX, Inc.

      • 14.9.1 MenoGeniX, Inc. Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 142 Figures and 168 Tables)

     

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Estetrol from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Fezolinetant from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of FP-101 from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of HBN-2 from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Homecare from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Vasomotor Symptoms of Menopause Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Vasomotor Symptoms of Menopause Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Vasomotor Symptoms of Menopause Treatment by Different Types from 2014 to 2026

    • Table Consumption Share of Vasomotor Symptoms of Menopause Treatment by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Estetrol

    • Figure Market Size and Growth Rate of Fezolinetant

    • Figure Market Size and Growth Rate of FP-101

    • Figure Market Size and Growth Rate of HBN-2

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Vasomotor Symptoms of Menopause Treatment by Different End-Users from 2014 to 2026

    • Table Consumption Share of Vasomotor Symptoms of Menopause Treatment by Different End-Users from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Homecare from 2014 to 2026

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Clinic from 2014 to 2026

    • Table Japan Vasomotor Symptoms of Menopause Treatment Production by Regions

    • Table Japan Vasomotor Symptoms of Menopause Treatment Production Share by Regions

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Production Share by Regions in 2014

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Production Share by Regions in 2018

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Production Share by Regions in 2026

    • Table Japan Vasomotor Symptoms of Menopause Treatment Consumption by Regions

    • Table Japan Vasomotor Symptoms of Menopause Treatment Consumption Share by Regions

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Consumption Share by Regions in 2014

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Consumption Share by Regions in 2018

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Consumption Share by Regions in 2026

    • Table Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

    • Table Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

    • Figure Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

    • Figure Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

    • Table Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

    • Figure Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

    • Figure Hokkaido Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

    • Table Tohoku Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

    • Table Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

    • Figure Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

    • Figure Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

    • Table Tohoku Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

    • Table Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

    • Figure Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

    • Figure Tohoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

    • Table Kanto Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

    • Table Kanto Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

    • Figure Kanto Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

    • Figure Kanto Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

    • Figure Kanto Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

    • Table Kanto Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

    • Table Kanto Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

    • Figure Kanto Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

    • Figure Kanto Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

    • Table Chubu Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

    • Table Chubu Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

    • Figure Chubu Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

    • Figure Chubu Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

    • Figure Chubu Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

    • Table Chubu Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

    • Table Chubu Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

    • Figure Chubu Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

    • Figure Chubu Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

    • Table Kinki Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

    • Table Kinki Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

    • Figure Kinki Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

    • Figure Kinki Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

    • Figure Kinki Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

    • Table Kinki Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

    • Table Kinki Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

    • Figure Kinki Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

    • Figure Kinki Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

    • Table Chugoku Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

    • Table Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

    • Figure Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

    • Figure Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

    • Table Chugoku Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

    • Table Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

    • Figure Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

    • Figure Chugoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

    • Table Shikoku Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

    • Table Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

    • Figure Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

    • Figure Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

    • Table Shikoku Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

    • Table Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

    • Figure Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

    • Figure Shikoku Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

    • Table Kyushu Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

    • Table Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

    • Figure Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

    • Figure Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

    • Table Kyushu Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

    • Table Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

    • Figure Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

    • Figure Kyushu Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of EndoCeutics, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EndoCeutics, Inc.

    • Figure Sales and Growth Rate Analysis of EndoCeutics, Inc.

    • Figure Revenue and Market Share Analysis of EndoCeutics, Inc.

    • Table Product and Service Introduction of EndoCeutics, Inc.

    • Table Company Profile and Development Status of Mithra Pharmaceuticals S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mithra Pharmaceuticals S.A.

    • Figure Sales and Growth Rate Analysis of Mithra Pharmaceuticals S.A.

    • Figure Revenue and Market Share Analysis of Mithra Pharmaceuticals S.A.

    • Table Product and Service Introduction of Mithra Pharmaceuticals S.A.

    • Table Company Profile and Development Status of Amgen Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc.

    • Figure Sales and Growth Rate Analysis of Amgen Inc.

    • Figure Revenue and Market Share Analysis of Amgen Inc.

    • Table Product and Service Introduction of Amgen Inc.

    • Table Company Profile and Development Status of Euroscreen S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Euroscreen S.A.

    • Figure Sales and Growth Rate Analysis of Euroscreen S.A.

    • Figure Revenue and Market Share Analysis of Euroscreen S.A.

    • Table Product and Service Introduction of Euroscreen S.A.

    • Table Company Profile and Development Status of Pherin Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pherin Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Pherin Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Pherin Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Pherin Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Euroscreen SA.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Euroscreen SA.

    • Figure Sales and Growth Rate Analysis of Euroscreen SA.

    • Figure Revenue and Market Share Analysis of Euroscreen SA.

    • Table Product and Service Introduction of Euroscreen SA.

    • Table Company Profile and Development Status of Mithra Pharmaceuticals SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mithra Pharmaceuticals SA

    • Figure Sales and Growth Rate Analysis of Mithra Pharmaceuticals SA

    • Figure Revenue and Market Share Analysis of Mithra Pharmaceuticals SA

    • Table Product and Service Introduction of Mithra Pharmaceuticals SA

    • Table Company Profile and Development Status of Pivot Pharmaceuticals Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pivot Pharmaceuticals Inc.

    • Figure Sales and Growth Rate Analysis of Pivot Pharmaceuticals Inc.

    • Figure Revenue and Market Share Analysis of Pivot Pharmaceuticals Inc.

    • Table Product and Service Introduction of Pivot Pharmaceuticals Inc.

    • Table Company Profile and Development Status of MenoGeniX, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MenoGeniX, Inc.

    • Figure Sales and Growth Rate Analysis of MenoGeniX, Inc.

    • Figure Revenue and Market Share Analysis of MenoGeniX, Inc.

    • Table Product and Service Introduction of MenoGeniX, Inc.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US